Through utilizing the A-ZIP/F1 genetic lipoatrophic mouse model, the present study determined that vaspin exhibited cardioprotective benefits in lipoatrophy, which facilitated the further clinical application of vaspin in combating lipoatrophy-related cardiomyopathy. The gene discussed is SERPINA12; the disease is cardiomyopathy.